Hemo Organic's Q1 revenue nil, auditor flags books again
No revenue from operations for the quarter ended June 2026, down from ₹92.70 lakh in the prior quarter. Net loss narrowed to ₹7.42 lakh but the auditor again qualified the opinion citing unverified trade balances.
— 1 earlier story on Hemo Organic Ltd. →What's new
- Revenue from operations dropped to nil from ₹92.70 lakh in the preceding quarter.
- Net loss of ₹7.42 lakh, narrower than the prior quarter's ₹50.57 lakh loss but wider than the year-ago ₹8.57 lakh loss.
- Statutory auditor again issued a qualified opinion due to unverified trade receivable and payable balances.
Why this matters
Zero revenue for a ₹7 crore market cap pharma company raises business continuity questions. The persistent auditor qualification makes the financials unreliable. This is a governance flag as much as a performance miss.
What we're watching
- Whether revenue reappears in the September quarter.
- Any management response to the auditor's concerns on trade balances.
- If the board addresses the going-concern implications of nil revenue.
The full read
Hemo Organic's revenue vanished in the June quarter. From ₹92.70 lakh three months ago, it fell to nil - no revenue from operations at all. The net loss of ₹7.42 lakh was smaller than the preceding quarter's ₹50.57 lakh but still wider than the year-ago loss of ₹8.57 lakh. The auditor again refused to confirm trade receivables and payables, repeating a pattern from the annual results. For a ₹7 crore market cap pharma company, zero revenue isn't just a bad quarter. It raises real questions about whether the business is still running. The loss narrowing is cold comfort when the top line has disappeared and the books can't be verified. The board hasn't yet explained any of this.
Questions answered
- Why did revenue drop to zero?
- The company reported no revenue from operations for Q1 June 2026. The filing gives no reason, but revenue had already fallen 63% in FY26 from the prior year.
- How does the net loss compare to previous periods?
- The net loss of ₹7.42 lakh is narrower than the preceding quarter's ₹50.57 lakh loss but worse than the ₹8.57 lakh loss in the year-ago quarter.
- What does the qualified opinion mean?
- The auditor says it could not verify trade receivables and payables because supporting documents were not provided. This is the same issue flagged in the previous annual results.
- Is this a going-concern problem?
- With nil revenue and a qualified audit opinion, the risk of a going-concern issue increases. However, the company has not explicitly flagged it.
- What is the company's market cap and recent financial performance?
- Market cap is about ₹7 crore. For FY26, it reported a net loss of ₹77.81 lakh compared to a profit of ₹16.39 lakh in FY25.
Hemo Organic Ltd.
Latest quarter · Jun 2026
Strength & growth
Story so far
All notes on HEMORGANIC →- 15 Jul 2026 · 5:50 PM IST Hemo Organic's Q1 revenue nil, auditor flags books again
- 60d ago Hemo Organic's revenue fell 63%. Its auditors can't confirm the books.